GHK (Gly-His-Lys) Dosage Guide

Evidence-based protocols for the naturally occurring gene-modulating tripeptide — topical, subcutaneous, and research dosing for anti-aging gene expression, skin remodeling, wound healing, and stacking strategies.

Compiled by PeptideWiki Editorial Team·Last reviewed February 24, 2026

A leading innovator in research chemicals.

All products HPLC tested

|Exclusive Offer

Coupon

10%

Off

Use our affiliate link and code PEPTIDEWIKI at checkout to unlock your 10% discount, every time you use the code.

Shop Now

For research purposes only. PeptideWiki may earn a commission at no extra cost to you.

Research Peptides

GHK

For research purposes only. PeptideWiki may earn a commission at no extra cost to you.

What Is GHK?

GHK (Glycyl-L-Histidyl-L-Lysine) is a naturally occurring tripeptide found in human plasma, saliva, and urine. It was first isolated from human plasma albumin by Dr. Loren Pickart in 1973, when he observed that plasma from young donors (age 20–25) could stimulate old liver tissue to synthesize proteins at a rate characteristic of younger tissue — and that GHK was the active factor responsible. Plasma GHK levels are approximately 200 ng/mL in young adults and decline to roughly 80 ng/mL by age 60.

What makes GHK remarkable is its broad gene expression activity. Research has shown that GHK modulates the expression of approximately 4,000 human genes — roughly 6% of the human genome. It upregulates genes involved in tissue repair, collagen synthesis, antioxidant defense, nerve growth, and stem cell activity, while simultaneously downregulating genes associated with inflammation, tissue destruction, fibrosis, and DNA damage. This gene-resetting activity is believed to shift cellular behavior toward a younger, more repair-oriented phenotype.

GHK has an extremely high natural affinity for copper(II) ions, and in the body it readily forms the GHK-Cu complex. However, free GHK (without copper) retains significant biological activity through its gene expression modulation pathways, which operate independently of copper-dependent enzymatic mechanisms. This makes free GHK and GHK-Cu complementary but distinct in their primary mechanisms of action.

Use our Peptide Dosage to calculate your exact subcutaneous dose based on vial size and concentration.

Dosing information in this guide is derived from published research and community protocols.

Key Characteristics:

Naturally occurring human tripeptide — found in plasma, saliva, and urine; first isolated by Dr. Loren Pickart in 1973 from human plasma albumin
Broad gene expression modulation — modulates ~4,000 human genes (~6% of genome); upregulates repair, collagen, antioxidant, and stem cell genes while downregulating inflammatory, fibrotic, and damage genes
Age-related decline — plasma levels drop ~60% from age 20 to age 60 (200 ng/mL → 80 ng/mL), correlating with reduced regenerative capacity
High copper affinity — readily binds copper(II) to form GHK-Cu in vivo, but free GHK retains independent biological activity through gene expression pathways
Multiple administration routes — topical (most common for skin), subcutaneous injection (research), intranasal (experimental); oral bioavailability not well-established
Excellent safety profile — naturally occurring peptide with no hormone manipulation, no receptor desensitization, no known tolerance development; widely used in cosmetic products topically

For the copper-bound form, see our GHK-Cu Dosage Guide. New to peptides? Start with the Beginner's Guide to Peptides.

GHK vs. GHK-Cu: Understanding the Difference

Because GHK and GHK-Cu are closely related, understanding their differences is essential for choosing the right protocol. They share the same peptide backbone but differ in their primary mechanisms and optimal use cases.

Parameter	GHK (Free Tripeptide)	GHK-Cu (Copper Complex)
Structure	Gly-His-Lys (no metal ion)	Gly-His-Lys + Cu(II) ion
Primary Mechanism	Gene expression modulation (~4,000 genes)	Copper-dependent enzymatic activity + gene modulation
Key Strength	Broad gene resetting — repair, anti-aging, anti-inflammatory gene profiles	Direct collagen synthesis, wound healing, extracellular matrix remodeling
Injectable Dose Range	50–200 mcg/day	1–2 mg/day
Topical Use	1–5% in serums	1–2% in serums (more clinical data)
Best For	Anti-aging gene expression, systemic repair signaling, preventive protocols	Wound healing, collagen production, skin rejuvenation, hair growth
Clinical Data	Strong preclinical gene expression data; limited human clinical trials	Multiple human skin studies; more established clinical evidence
In Vivo Behavior	Readily binds available copper to form GHK-Cu in the body	Delivers copper directly to target tissue

They are complementary, not competing. Free GHK provides the gene expression “software update” — reprogramming cells toward repair-oriented behavior across thousands of genes. GHK-Cu provides the “building materials” — copper-dependent enzymes like lysyl oxidase (collagen cross-linking) and superoxide dismutase (antioxidant defense). Many research protocols use both forms together for comprehensive anti-aging and repair support.

How GHK Dosage Is Determined

GHK dosing is informed by a combination of gene expression research, preclinical studies, cosmetic product formulation data, and research community protocols. Because free GHK acts primarily through gene expression modulation (rather than direct enzymatic activity like GHK-Cu), effective doses tend to be lower — signaling molecules require smaller quantities than structural building materials.

Gene Expression Studies (Pickart, Campbell, et al.)

The foundational research by Pickart and colleagues demonstrated that GHK modulates approximately 4,000 human genes using the Broad Institute Connectivity Map (cMap) database. These studies showed that GHK at micromolar concentrations could reset gene expression patterns in human cells — upregulating repair and anti-aging genes while downregulating inflammatory and damage-associated genes. The effective concentrations observed in cell culture studies inform the microgram-range dosing used in subcutaneous protocols.

Cosmetic Formulation Data

GHK and GHK-Cu have been used in commercial skincare products for decades. Topical formulations typically contain 1–10% GHK or GHK-Cu, with most clinical studies using 1–2% concentrations. These formulations have established the topical dose range that produces measurable skin improvements (collagen density, firmness, fine line reduction) in controlled studies.

Preclinical Wound Healing & Tissue Repair Studies

Animal studies have demonstrated GHK's ability to accelerate wound healing, attract immune cells and endothelial cells to wound sites, stimulate collagen synthesis, and promote nerve growth. These studies used doses in the microgram-range per application, supporting the low-dose subcutaneous protocols used in research settings.

Endogenous Levels as a Reference

Because GHK is naturally present in human plasma (~200 ng/mL in young adults, declining to ~80 ng/mL by age 60), endogenous levels provide a physiological reference point. Research protocols aim to restore youthful GHK signaling levels rather than achieve supraphysiological concentrations — which is why doses are relatively modest compared to many other research peptides.

Strength of evidence: Strong preclinical, limited clinical (injectable). GHK has robust gene expression data from the Broad Institute cMap, extensive preclinical wound healing studies, and established cosmetic use (topical). However, published human clinical trials specifically for injectable free GHK are limited. Most human clinical data comes from topical GHK-Cu formulations. Injectable dosing protocols are based on preclinical pharmacology and research community experience.

Standard GHK Dosage Ranges

GHK dosing varies significantly by route. Topical use is the most established (with commercial product data), while subcutaneous injection protocols come from the research community. Intranasal dosing is experimental with very limited data.

Topical Application

Level	Concentration	Frequency	Notes
Entry Level	1–2% GHK serum	1x daily (PM)	Start here; matches most commercial product concentrations
Standard	2–5% GHK serum	1–2x daily (AM/PM)	Most common effective range for skin rejuvenation and anti-aging
Higher Range	5–10% GHK serum	1–2x daily	Upper end; used for targeted skin repair and accelerated protocols

Subcutaneous Injection

Level	Dose per Injection	Frequency	Daily Total	Notes
Starting	50 mcg	1x daily	50 mcg	Assess tolerance for first 5–7 days
Standard	100–150 mcg	1x daily	100–150 mcg	Most common research protocol for systemic gene modulation
Higher Range	200 mcg	1x daily	200 mcg	Upper end of reported research protocols; for targeted repair

Intranasal (Experimental)

Dose: 50–100 mcg per session
Frequency: 1x daily
Data quality: Very limited; experimental route with minimal published data for GHK specifically
Rationale: Mucosal absorption bypasses GI degradation; may provide CNS access for neuroprotective gene expression

Why are GHK injectable doses so much lower than GHK-Cu? Free GHK acts primarily as a signaling molecule — it triggers gene expression changes at very low concentrations. GHK-Cu requires higher doses because it functions as both a signaling molecule AND a copper delivery vehicle for enzymatic processes (lysyl oxidase, superoxide dismutase) that require stoichiometric copper. Signaling requires less material than structural building.

Administration Routes Compared

Each GHK administration route has distinct advantages. The optimal choice depends on whether you are targeting skin rejuvenation, systemic gene modulation, or neuroprotective effects.

Parameter	Topical	Subcutaneous	Intranasal
Typical Dose	1–10% serum	50–200 mcg	50–100 mcg
Bioavailability	Local dermal delivery	Highest systemic	Moderate (mucosal)
Best For	Skin rejuvenation, anti-aging	Systemic gene modulation, repair	Neuroprotection (experimental)
Evidence Level	Best established (cosmetic data)	Preclinical + community	Very limited
Ease of Use	Easiest (apply to skin)	Requires injection	Easy (spray)
Community Popularity	Most popular	Growing research use	Niche / experimental
Key Advantage	Proven skin delivery; OTC products	Reliable systemic gene modulation	Potential CNS access

Topical is the most proven route for GHK. Unlike many research peptides where injection is the gold standard, GHK and GHK-Cu have their strongest human evidence base in topical formulations. Multiple controlled studies have demonstrated that topical GHK/GHK-Cu improves collagen density, skin firmness, and fine lines. If your primary goal is skin anti-aging, topical is the first-line approach. Subcutaneous injection is the preferred route for systemic gene expression modulation beyond the skin.

Calculate Your GHK Dose

For subcutaneous injection, GHK is supplied as a lyophilized (freeze-dried) powder, typically in 5 mg vials. You reconstitute it with bacteriostatic water, then draw your dose using an insulin syringe. Because GHK doses are small (50–200 mcg), precise reconstitution is important to ensure accurate dosing. For topical products, dosing is pre-formulated — no reconstitution math is needed.

Worked Example (Subcutaneous):

Vial size: 5 mg (5,000 mcg) of GHK
Bacteriostatic water added: 2 mL
Concentration: 5,000 mcg ÷ 2 mL = 2,500 mcg per mL
Target dose: 100 mcg
Volume to draw: 100 ÷ 2,500 = 0.04 mL = 4 units on an insulin syringe

Quick Reference — 5 mg Vial (Subcutaneous)

Bac Water Added	Concentration	100 mcg Dose	200 mcg Dose
1 mL	5,000 mcg/mL	2 units (0.02 mL)	4 units (0.04 mL)
2 mL	2,500 mcg/mL	4 units (0.04 mL)	8 units (0.08 mL)
2.5 mL	2,000 mcg/mL	5 units (0.05 mL)	10 units (0.1 mL)
5 mL	1,000 mcg/mL	10 units (0.1 mL)	20 units (0.2 mL)

Small volumes require precision. At lower reconstitution volumes (1 mL of water), a 100 mcg dose is only 2 units (0.02 mL) on an insulin syringe — very small and easy to mis-measure. For GHK, adding 2.5–5 mL of bacteriostatic water gives more practical injection volumes (5–10 units for a standard dose). The tradeoff is the vial will contain more injections but each one uses more liquid.

Skip the Math — Use Our

Enter your vial size, water volume, and desired dose — get instant calculations with zero manual math.

GHK Dosage by Goal

GHK's broad gene expression modulation makes it applicable to multiple goals. The optimal protocol varies depending on whether you are targeting skin anti-aging, systemic repair, wound healing, hair growth, or neuroprotection.

Skin Anti-Aging & Rejuvenation

The most established use case for GHK. Topical application delivers the peptide to the dermal layer where it modulates gene expression in fibroblasts and keratinocytes — upregulating collagen, elastin, and glycosaminoglycan production while downregulating matrix metalloproteinases (enzymes that break down skin matrix).

Route: Topical (serum or cream)
Concentration: 2–5% GHK in a properly formulated serum
Frequency: 1–2x daily (AM and/or PM after cleansing)
Duration: Ongoing; visible results typically at 4–8 weeks
Stack: + topical GHK-Cu serum for complementary copper-dependent collagen cross-linking + retinoid (alternate evenings) for synergistic anti-aging

Systemic Anti-Aging & Gene Expression Reset

For whole-body anti-aging beyond skin, subcutaneous GHK targets systemic gene expression modulation — shifting the body's cellular programs toward repair-oriented, anti-inflammatory, and regenerative patterns. This protocol aims to counteract the age-related decline in endogenous GHK levels.

Route: Subcutaneous injection
Dose: 100–200 mcg per injection
Frequency: 1x daily
Duration: 8–12 weeks; reassess at 8 weeks
Stack: + Epitalon 5–10 mg daily for telomere and pineal anti-aging support (gene expression + telomerase activation)

Wound Healing & Tissue Repair

GHK accelerates wound healing by attracting immune cells and endothelial cells to wound sites, promoting angiogenesis, stimulating collagen deposition, and modulating the inflammatory-to-proliferative phase transition. Works synergistically with GHK-Cu which adds copper-dependent enzymatic support.

Route: Topical (to wound site) + SubQ (systemic support)
Dose: Topical GHK/GHK-Cu serum to wound area + SubQ GHK 100–200 mcg daily
Duration: Until healing is satisfactory; typically 2–8 weeks
Stack: + BPC-157 250–500 mcg + TB-500 750 mcg for comprehensive healing (gene modulation + angiogenesis + tissue remodeling)

Hair Growth Support

GHK supports hair growth through multiple gene expression pathways: upregulation of Wnt signaling (hair follicle stem cell activation), increased VEGF expression (blood flow to follicles), and modulation of genes involved in hair follicle cycling. Preclinical data shows increased follicle size in mouse models.

Route: Topical (to scalp) + optional SubQ
Topical: 2–5% GHK serum applied to scalp 1x daily
Optional SubQ: 100–200 mcg daily for systemic support
Duration: 8–12+ weeks minimum; hair growth is slow
Stack: + topical GHK-Cu (copper-dependent growth factor activity) + oral finasteride or topical minoxidil (conventional options, consult a dermatologist)

Lung Tissue Repair (Experimental)

Emerging preclinical research suggests GHK may support lung tissue remodeling through gene expression modulation. GHK has been shown to modulate genes involved in extracellular matrix remodeling in lung fibroblasts and to reverse gene expression signatures associated with pulmonary fibrosis in bioinformatics analyses. This is an early-stage research area.

Route: Subcutaneous injection (nebulized delivery is experimental)
Dose: 100–200 mcg SubQ daily
Duration: 8–12 weeks
Evidence level: Bioinformatics + preclinical only; no human clinical data for pulmonary applications

Match the form to the goal. For skin-specific goals, topical GHK or GHK-Cu is the first choice (proven dermal delivery, best evidence base). For systemic anti-aging and gene expression goals, subcutaneous GHK provides reliable systemic delivery. For wound healing, combining topical + SubQ covers both local and systemic repair pathways. For hair growth, topical to scalp is the primary route with optional systemic support.

Cycling & Duration

GHK does not act on cell-surface receptors that downregulate with continuous exposure. Its gene expression modulation mechanism does not involve the same tolerance/desensitization patterns seen with GHRPs or melanocortin agonists. Topical GHK can be used continuously (as with cosmetic products), while injectable protocols typically follow structured cycles as a general best practice for research peptides.

Protocol	On-Period	Off-Period	Notes
Topical (Skin)	Ongoing / continuous	No cycling needed	Consistent with cosmetic product usage; safe for continuous topical use
Injectable Standard	8–12 weeks	4 weeks off	Most common research protocol; allows reassessment of gene expression outcomes
Injectable Short	4–6 weeks	2–4 weeks off	For targeted repair goals (wound healing, recovery); shorter timeline
Anti-Aging Maintenance	12 weeks on	4–8 weeks off	Long-cycle approach for systemic anti-aging; repeat 2–3x per year
Hair Growth	12–16+ weeks (topical)	Assess before stopping	Hair follicle cycling is slow; requires extended consistent use

Topical does not need cycling. Because GHK occurs naturally in the skin and topical products deliver it locally without systemic accumulation, continuous daily use is standard practice — just like any active skincare ingredient. Cycling recommendations apply primarily to injectable protocols, where periodic off-periods allow reassessment of progress and follow general research peptide best practices.

When to Extend or Shorten a Cycle

Extend beyond 12 weeks if systemic anti-aging or hair growth protocols are showing gradual improvement that has not yet plateaued.
Shorten to 4–6 weeks if using GHK for a targeted repair goal (wound healing, post-procedure recovery) that resolves within that timeframe.
Consider seasonal cycling for anti-aging: 12-week injectable cycles 2–3 times per year, with continuous topical use year-round.
No need to taper. GHK does not cause dependency or withdrawal. Simply discontinue at the end of the cycle and resume after the off-period.

GHK Stacking Protocols

GHK's gene expression modulation mechanism is mechanistically distinct from most other peptides, making it highly compatible for stacking. It provides the “software” (gene reprogramming) while other peptides provide the “hardware” (structural repair, growth factors, immune modulation).

GHK + GHK-Cu — The Complete GHK Stack (Most Popular)

The most natural combination — pairing the free tripeptide with its copper-bound form. GHK provides broad gene expression modulation (the signaling component), while GHK-Cu adds copper-dependent enzymatic activity for direct collagen synthesis and extracellular matrix remodeling (the structural component). Together they replicate and enhance the full spectrum of GHK biology.

Compound	Dose	Route	Purpose
GHK	100–200 mcg, 1x daily	SubQ	Systemic gene expression modulation; anti-aging signaling
GHK-Cu	1–2 mg, 1x daily (or topical 1–2%)	SubQ or Topical	Copper-dependent collagen synthesis; matrix remodeling; wound healing

Protocol note: A common approach combines SubQ GHK (systemic gene modulation) with topical GHK-Cu serum (targeted skin collagen). This avoids two separate daily injections while covering both systemic and localized pathways. For maximum wound healing, SubQ of both forms can be used.

GHK + Epitalon (Anti-Aging Gene Expression + Telomere Support)

Combines GHK's gene expression resetting with Epitalon's telomerase activation and pineal gland support. GHK shifts gene expression toward youthful repair patterns, while Epitalon targets telomere maintenance — addressing two different dimensions of cellular aging.

Compound	Dose	Route	Purpose
GHK	100–200 mcg, 1x daily	SubQ	Gene expression modulation; repair gene upregulation
Epitalon	5–10 mg, 1x daily	SubQ	Telomerase activation; pineal function; melatonin regulation

GHK + BPC-157 (Gene Modulation + Tissue Repair)

Pairs GHK's broad gene expression modulation with BPC-157's targeted tissue repair mechanisms (angiogenesis, growth factor expression, nitric oxide modulation). GHK reprograms cells toward repair mode at the gene level, while BPC-157 directly stimulates the repair processes at the tissue level.

Compound	Dose	Route	Purpose
GHK	100–200 mcg, 1x daily	SubQ	Gene expression modulation; repair gene activation
BPC-157	250–500 mcg, 1–2x daily	SubQ or Oral	Angiogenesis; growth factor upregulation; localized tissue repair

GHK + Matrixyl 3000 (Topical Anti-Aging Stack)

A topical-only stack combining GHK's gene expression modulation with Matrixyl 3000 (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7), another peptide complex that stimulates collagen and hyaluronic acid production. This combination targets skin aging through multiple peptide signaling pathways without any injection.

Compound	Dose	Route	Purpose
GHK or GHK-Cu serum	2–5% serum, 1–2x daily	Topical	Gene expression modulation; collagen and elastin upregulation
Matrixyl 3000	Per product formulation, 1–2x daily	Topical	Collagen stimulation; hyaluronic acid production; skin matrix support

Do NOT confuse GHK dose ranges with GHK-Cu dose ranges. Free GHK is typically dosed at 50–200 mcg SubQ, while GHK-Cu is dosed at 1–2 mg SubQ. These are different by a factor of 5–20x. Always verify which form you are using before calculating your dose. Using GHK-Cu doses for free GHK would be excessive; using free GHK doses for GHK-Cu would likely be insufficient for copper-dependent effects.

Explore more combinations with our Peptide Stack Builder or browse the Top 10 Peptide Stacks guide.

Safety, Side Effects & Contraindications

Safety Profile: GHK is a naturally occurring tripeptide present in human blood, saliva, and urine throughout life. It does not manipulate hormones, does not activate cell-surface receptors that desensitize, and does not affect endocrine feedback loops. Topical GHK has been used in commercial cosmetic products for years without safety concerns. Injectable GHK has no reported serious adverse effects in published research. However, long-term human injectable safety data is limited, and injectable GHK remains a research peptide — not an approved drug.

Reported Side Effects

Rare and generally very mild:

Injection site reactions (SubQ route) — minor redness, soreness, or swelling at the injection site; standard for any subcutaneous peptide injection
Mild skin irritation (topical route) — rare; possible in individuals with very sensitive or reactive skin; usually resolves with reduced frequency
Rare mild headache — reported by a very small number of users with injectable protocols; typically transient

NOT associated with GHK:

No hormonal effects (does not affect testosterone, estrogen, GH, cortisol, or insulin)
No appetite changes
No sleep disruption
No mood alterations
No water retention or bloating
No receptor desensitization or tolerance (gene expression modulation does not downregulate with continued use)
No known drug interactions (though always consult a healthcare provider)

One of the safest research peptides available. Because GHK is an endogenous peptide (the body already produces it), the risk of adverse immune reactions is extremely low. Its mechanism of action (gene expression modulation) is subtle and broadly beneficial rather than targeted at a single receptor or hormonal pathway. This gives GHK one of the most favorable safety profiles in the research peptide space. That said, the body produces GHK at specific levels for a reason — exogenous supplementation is still an intervention that should be approached thoughtfully.

Contraindications

Pregnancy and breastfeeding — no safety data exists for exogenous GHK supplementation during pregnancy or nursing. Avoid injectable use entirely. Topical cosmetic products may be acceptable but consult a healthcare provider.
Wilson's disease or copper metabolism disorders — because GHK binds copper with high affinity, individuals with copper metabolism disorders should exercise caution and consult their physician. GHK could theoretically alter copper distribution in the body.
Active cancer — GHK modulates genes involved in cell growth, proliferation, and stem cell activity. While some gene expression changes may be protective (upregulation of DNA repair genes), the broad gene modulation profile has not been studied in the context of active malignancy. Consult an oncologist before using GHK with active cancer.
Known peptide hypersensitivity — discontinue use if allergic reactions occur (rash, hives, difficulty breathing).

When to Stop or Reduce Dose

Any signs of allergic reaction (rash, hives, swelling, difficulty breathing) — extremely rare with an endogenous peptide
Persistent injection site reactions that worsen rather than improve over time
Persistent skin irritation from topical use (try reducing frequency or concentration first)
Onset of new symptoms that correlate with starting GHK (headache, malaise) — reduce dose and reassess
Any concerning symptom — err on the side of caution with any research peptide

Regulatory Status: GHK and GHK-Cu are used in commercial cosmetic products globally (topical). Injectable GHK is classified as a research peptide and is not FDA-approved for human therapeutic use. Topical GHK-Cu products are widely available over the counter. Regulations for injectable peptides vary by jurisdiction — verify your local laws before purchasing.

Common GHK Dosing Mistakes

Avoid these common errors to get the most out of your GHK protocol:

Confusing GHK with GHK-Cu and using the wrong dose: Free GHK and GHK-Cu have different dosing ranges. GHK-Cu injectable protocols typically use 1–2 mg daily, while free GHK research protocols use 50–200 mcg daily. Applying GHK-Cu doses to free GHK (or vice versa) will result in either excessive or insufficient dosing. Always confirm which form you have before calculating your dose.

Expecting immediate visible results from gene expression modulation: GHK’s primary mechanism is gene expression modulation across thousands of genes. While cellular changes begin within hours, the visible phenotypic results (improved skin, better healing, reduced inflammation markers) take weeks to manifest. Topical skin improvements typically require 4–8 weeks; systemic benefits from injectable protocols may take 4–12 weeks. Do not abandon the protocol prematurely.

Megadosing copper alongside GHK: Some users take high-dose copper supplements thinking it will enhance GHK’s activity by providing more copper for GHK-Cu formation in vivo. This is dangerous. Excess copper is toxic and can cause liver damage, GI distress, and oxidative stress. GHK naturally binds available dietary copper with very high affinity. Normal dietary copper intake (1–2 mg/day) is sufficient. Never take copper supplements above the tolerable upper intake level (10 mg/day for adults).

Using GHK topically without proper formulation: Free GHK is a water-soluble tripeptide. Simply mixing reconstituted GHK powder with a generic moisturizer does not guarantee effective skin penetration. Commercial GHK and GHK-Cu serums use specific delivery vehicles (liposomes, penetration enhancers, optimal pH buffering) to ensure the peptide reaches the dermal layer. For topical use, using a properly formulated product is recommended over DIY preparations.

Not storing reconstituted GHK properly: Like all reconstituted peptides, GHK solution should be stored refrigerated (2–8°C) and used within 3–4 weeks. Do not leave reconstituted vials at room temperature or expose them to direct light. Use bacteriostatic water for reconstitution to prevent bacterial growth. Lyophilized (unreconstituted) GHK should also be stored refrigerated for maximum potency.

Assuming oral GHK has proven efficacy: While GHK’s small tripeptide size theoretically allows some GI absorption, oral dosing protocols for free GHK are not well-established in the research literature. Most evidence for GHK comes from topical and injectable studies. Do not assume oral delivery will provide equivalent gene expression modulation to subcutaneous injection or properly formulated topical products.

Ignoring the difference between cosmetic and research-grade GHK: GHK used in commercial skincare products may differ in purity, concentration, and formulation from research-grade lyophilized GHK intended for reconstitution and injection. Cosmetic-grade products are designed for topical application only. Never inject a cosmetic product. For injectable protocols, use research-grade lyophilized GHK from reputable sources with certificates of analysis.

Frequently Asked Questions

Key Takeaways

GHK (Gly-His-Lys) is a naturally occurring human tripeptide — discovered by Dr. Loren Pickart in 1973; found in plasma, saliva, and urine; levels decline ~60% from age 20 to 60
Modulates ~4,000 human genes — upregulates repair, collagen, antioxidant, and stem cell genes; downregulates inflammatory, fibrotic, and damage genes; shifts cells toward a younger phenotype
Different from GHK-Cu: free GHK emphasizes gene expression modulation (signaling); GHK-Cu adds copper-dependent enzymatic activity (structural repair). They are complementary, not competing
Topical is the most proven route: 2–5% GHK serum applied 1–2x daily — strongest human evidence base (cosmetic studies)
SubQ for systemic gene modulation: 50–200 mcg daily — much lower doses than GHK-Cu (1–2 mg) because signaling requires less material than structural building
Best stack: GHK + GHK-Cu for the complete GHK biology (gene modulation + copper-dependent repair)
Anti-aging stack: + Epitalon for gene expression reset + telomere maintenance
Cycling: topical is continuous (no cycling needed); injectable 8–12 weeks on, 4 weeks off
Excellent safety profile — endogenous peptide with no hormonal effects, no receptor desensitization, no known tolerance; widely used in cosmetic products topically
Caution: not FDA-approved for injectable use; strong preclinical data but limited human clinical trials for injectable protocols. Consult a healthcare provider.

This article is for educational and informational purposes only. See our Disclaimer.

References

Pickart L. “The human tri-peptide GHK and tissue remodeling.” J Biomater Sci Polym Ed. 2008;19(8):969-988. PubMed
Pickart L, Vasquez-Soltero JM, Margolina A. “GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.” Biomed Res Int. 2015;2015:648108. PubMed
Pickart L, Vasquez-Soltero JM, Margolina A. “The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.” Oxid Med Cell Longev. 2012;2012:324832. PubMed
Campbell JD, McDonough JE, et al. “A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK.” Genome Med. 2012;4(10):67. PubMed
Pickart L, Margolina A. “Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.” Int J Mol Sci. 2018;19(7):1987. PubMed
Leyden JJ, et al. “Skin care benefits of copper peptide containing facial cream.” Cosmet Dermatol. 2002;15(10):13-18.
Finkley MB, Appa Y, Bhandarkar S. “Copper peptide and skin.” Cosmeceuticals and Active Cosmetics. CRC Press; 2005:549-563.
Hong Y, Downey T, et al. “A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics.” Clin Exp Metastasis. 2010;27(2):83-90. PubMed
Maquart FX, et al. “Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.” FEBS Lett. 1988;238(2):343-346. PubMed

Next Steps

Continue your research with these resources.

GHK-Cu Dosage Guide

Learn dosing protocols for the copper-bound form — injectable and topical protocols for collagen synthesis and wound healing.

Read Guide

Dosage Calculator

Calculate your exact GHK subcutaneous dose based on vial size and reconstitution volume.

Open Calculator

Peptide Directory

Browse all peptides with research summaries and dosing data.

View Directory